WaradyB.A., HebertD., SullivanE.K., AlexanderS.R., TejaniA.Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.Pediatr Nephrol.1997; 11: 49–64.
2.
GokaI.R., RamosJ.M., McGurkJ.G., WardM.K., KerrD.N.S.Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis. In: GahlG.M., KesselM., NolphK.D., eds. Advances in Peritoneal Dialysis.Amsterdam: Excerpta Medica; 1981: 430–5.
3.
StefanidisC.J., HewittI.K., BalfeJ.W.Growth in children receiving continuous ambulatory peritoneal dialysis.J Pediatr.1983; 102: 681–5.
4.
SaluskiI.B., FineR.N., NelsonD., BlumenkrantzM.J., KoppleJ.D.Nutritional status of children undergoing continuous ambulatory peritoneal dialysis.Am J Clin Nutr.1983; 38: 599–611.
5.
GiordanoC., De SantoN.G., CapodicasaG., Di LeoV.A., Di SerafinoA., CirilloD.Amino acids losses during CAPD.Clin Nephrol.1980; 14: 230–2.
BroyerM., NiaudetP., ChampionG., JeanG., ChopinN., CzernichowP.Nutritional and metabolic studies in children on continuous ambulatory peritoneal dialysis.Kidney Int.1983; 24(Suppl 15): S106–10.
8.
CanepaA., PerfumoF., CarreaA., MenoniS., TrivelliA., DelucchiP.Nutritional status in children receiving chronic peritoneal dialysis.Perit Dial Int.1996; 16(Suppl 1): S526–31.
9.
RandersonD.H., ChapmanG.V., FarrelP.C.Amino acid and dietary status in CAPD patients. In: AtkinsR., ThomsonN., FarrelP., eds. Peritoneal Dialysis.Edinburgh: Churchill Livingstone; 1981: 179–91.
10.
BergströmJ., FurstP., NoréeL.O., VinnarsE.Intracellular free amino acids in muscle tissue of patients with chronic uremia: The effect of peritoneal dialysis and infusion of essential amino acids.Clin Sci Mol Med.1978; 54: 51–60.
11.
CanepaA., PerfumoF., CarreaA., GiallongoF., VerrinaE., CantaluppiA.Long term effect of amino acid dialysis solution in children on continuous ambulatory peritoneal dialysis.Pediatr Nephrol.1991; 5: 215–19.
12.
LindholmB., AlvestrandA., FurstP., BergströmJ.Plasma and muscle free amino acids during continuous ambulatory peritoneal dialysis.Kidney Int.1986; 35: 1219–26.
13.
GrazianiG., CantaluppiA., CasatiS., CitterioA., PonticelliC., TriforioA.Branched chain and aromatic free amino acids in plasma and skeletal muscle of uremic patients undergoing hemodialysis and CAPD.Int J Artif Organs.1984; 7: 85–8.
14.
CanepaA., Divino FilhoJ.C., ForsbergA.M., PerfumoF., CarreaA., VerrinaE.Children on continuous ambulatory peritoneal dialysis: Muscle and plasma proteins, amino acids and nutritional status.Clin Nephrol.1996; 46: 125–31.
15.
BlumenkrantzM.J., KoppleJ.D., MoranJ.K., GrodsteinG.P., CoburnJ.W.Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis.Kidney Int.1981; 20: 78–82.
16.
LindholmB., AlvestrandA., FurstP., TranæusA., BergströmJ.Efficacy and clinical experience of CAPD. Stockholm, Sweden. In: AykimR., ThompsonN., FarrellP.C., eds. Peritoneal Dialysis.Edinburgh: Churchill Livingstone; 1988: 147–61.
17.
CanepaA., PerfumoF., CarreaA., MenoniS., VerrinaE., TrivelliA.Protein and caloric intake, nitrogen losses and nitrogen balance in children undergoing chronic peritoneal dialysis. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 326–9.
18.
ParkM.S., HeimbürgerO., BergströmJ., WaniewskiJ., WerynskiA., LindholmB.Peritoneal transport during dialysis with amino acid-based solutions.Perit Dial Int.1993; 13: 280–8.
19.
WilliamsP.F., MarlissE.B., OrenA., SteinA.N., KhannaR., PettitJ.Amino acid absorption following intraperitoneal administration in CAPD patients.Perit Dial Bull.1982; 2: 129–30.
20.
YoungG.A., DibbleJ.B., HobonS.M., TompskinL., GibsonJ., TurneyJ.H.The use of an amino-acid-based CAPD fluid over 12 weeks.Nephrol Dial Transplant.1989; 4: 285–92.
21.
GoodshipT.H., LloydS., McKenzieP.W., EarnshawM., SmeatonG., BartlettK.Short-term studies of the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis.Clin Sci (Colch).1987; 73: 471–8.
22.
HamingR.M., BalfeJ.W., ZlottinS.H.Effectiveness and nutritional consequences of amino acid-based vs. glucose-based dialysis solutions in infants and children receiving CAPD.Am J Clin Nutr.1987; 46: 22–30.
23.
CanepaA., PerfumoF., CarreaA., PiccardoM.T., CiardiM.R., CantaluppiA.Continuous ambulatory peritoneal dialysis (CAPD) of children with amino acid solution: Technical and metabolic aspects.Perit Dial Int.1990; 10: 215–20.
24.
LindholmB., WerynskiA., BergströmJ.Peritoneal dialysis with amino acid solution: Fluid and solute transport kinetics.Artif Organs.1988; 12: 2–10.
25.
BrunoM., BagnisC., MarangellaM., RoveraL., CantaluppiA., LinariF.CAPD with amino acid dialysis solution: A long-term cross-over study.Kidney Int.1989; 35: 1189–94.
26.
ScanzianiR., DozioB., lacuittiG.CAPD in diabetics: Use of amino acids. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Bulletin, 1990: 6: 53–5.
27.
KoppleJ.D., BernardD., MessanaJ., SwartzR., BergströmJ., LindholmB.Treatment of malnourished CAPD patient with an amino acid based dialysate.Kidney Int.1995; 47: 1148–57.
28.
FallerB., AparicioM., FaictD., De VosC., de PrecigoutV., LarroumetN.Clinical evaluation of an optimized 1.1 % amino acid solution for peritoneal dialysis.Nephrol Dial Transplant.1995; 10: 1432–7.
29.
YoungG.A., DibbleJ.B., TaylorA.E., KendallS., BrownjohnA.M.A longitudinal study of the effects of amino acidbased CAPD fluid on amino acid retention and protein losses.Nephrol Dial Transplant.1989; 4: 900–5.
30.
SteinhauerH.B., Lubrich-BirknerI., KlutheR., BaummanG., SchollmeyerP.Effects of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.Am J Nephrol.1992; 12: 61–7.
31.
MedcalfJ.F., WallsJ., HarrisK.P.G.Effects of glucose Nutrineal and icodextrin on fibronectin (FN), TGF-β and cell viability of human peritoneal mesothelial cells (HPMC) [Abstract].J Am Soc Nephrol.1997; 8: 181A.
32.
LordnejadM.R., GrabenseeB., PlumJ.The effects of alternative peritoneal dialysis solutions on cell viability, apoptosis, necrosis and cytokine expression in human monocytes [Abstract].J Am Soc Nephrol.1995; 6: 268A.
33.
BrulezH.F.H., DekkenH.A.T., OeD.L., VerbeelenD., ter WeeP.M., VerbrughH.A.Biocompatibility of a 1.1 % amino acid containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.Nephron.1996; 74: 26–32.
34.
BreborowiczA., WitowskiJ., WieczorowskaK., MartinsL., SerkesK.D., OreopoulosD.Toxicity of free radicals to mesothelial cells and peritoneal membrane.Nephron.1993; 65: 62–6.
35.
OrenA., WuG., AndersonG.H., MarlissE., KhannaR., PettitJ.Effective use of amino acid dialysate over four weeks in CAPD patients.Perit Dial Bull.1983; 3: 66–73.
36.
PedrsenF.B., DragsholtC., LaierE., FrifeltJ.J., TrostmannA.F., EkelundS.Alternate use of amino acid and glucose solutions in CAPD.Perit Dial Bull.1985; 5: 215–18.
37.
DombrosN., PrutisK., TongM., AndersonG.H., HarrisonJ., SombolosK.Six month overnight intraperitoneal amino acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients No effect on nutritional status.Perit Dial Int.1990; 10: 79–84.
38.
ArfeenS., GoodshipT.H., KirkwoodA., WardM.K.The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.Clin Nephrol.1990; 33: 192–9.
39.
RubinJ., GarnerT.Positive nitrogen balance after intraperitoneal administration of amino acids in 3 patients.Perit Dial Int.1994; 14: 223–6.
40.
De BisschopE., AlleinS., Van Der NiepenP., VerbeelenD., LuyparetR., OsteauxM.Effect of amino acid administration on uremic muscle metabolism: A 31 P-spectroscopy study.Kidney Int.1997; 51: 1182–7.
41.
QamarI.U., LevinL., BalfeJ.W., BalfeJ.A., SeckerD., ZlotkinS.Effects of 3 month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis.Perit Dial Int.1994; 14: 34–41.
42.
HondaM., KamiyamaY., HasegawaO., HoshinagaK., OgawaO., KawamuraT.Effect of short -term essential amino acid containing dialysate in young children on CAPD.Perit Dial Int.1991; 11: 76–80.
43.
JonesM.R., HagenT., VoneshE., MoranJ, the Nutrineal Study Group. Use of 1.1% amino acid dialysis solution to treat malnutrition in peritoneal dialysis patients [Abstract].J Am Soc Nephrol.1995; 6: 580.
44.
ScrimshowN.S.An analysis of past and present recommended dietary allowances for protein in health and disease.N Engl J Med.1976; 294: 198–204.
45.
Vande WalleJ., RaesA., Lutz-DettingerN., DejaeghereA.Is the use of mixed glucose and amino acid (AA) PD solutions safe for acute peritoneal dialysis? [Abstract] Perit Dial Int.1998; 18(Suppl 1): S69.
46.
PerfumoF., CanepaA., VerrinaE., CarreaA., MenoniS., Degl'lnnocentiM.L.Effects of the combined intraperitoneal infusion of amino acid and glucose in children treated with CCPD [Abstract].J Am Soc Nephrol.1994; 5: 501.
47.
CanepaA., PerfumoF., CarreaA., VerrinaE., MenoniS., TrivelliA.Long term effects of amino acid (AA) solutions in children on automated peritoneal dialysis (APD) [Abstract].J Am Soc Nephrol.1996; 7: 1441.
48.
BremA.S., MaazD., SheminD.G., WolfsonM.Use of amino acid peritoneal dialysate for one year in a child on CCPD.Perit Dial Int.1996; 16: 634–41.
